US Patent Issued to Tris Pharma on Sept. 15 for "Extended release amphetamine tablets" (New Jersey, Florida Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,132, issued on Sept. 15, was assigned to Tris Pharma Inc. (Monmouth Junction, N.J.).

"Extended release amphetamine tablets" was invented by Ketan Mehta (Miami) and Kalyan Kathala (Monmouth Junction, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An oral amphetamine extended release solid dose is described. The compositions contain a combination of an uncoated amphetamine-cation exchange resin complex, a barrier coated amphetamine-cation exchange resin complex-matrix, and an uncomplexed amphetamine, wherein one or more of these components contains blends of different forms of amphetamines. Either the modified release coated and/or the uncoated ...